The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000898
Collaborator
(none)
18
4
4.5
Study Details
Study Description
Brief Summary
The purpose of this study is to see if staggering doses of nelfinavir, ritonavir, and saquinavir has any effect on the interactions between these drugs.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
A Prototype Study to Test the Effect of Staggered Dosing on the Pharmacokinetic Interactions Between Paired Combinations of Nelfinavir (NFV), Ritonavir (RTV), and Soft Gelatin Capsule of Saquinavir (SQVsgc)
Actual Study Completion Date
:
May 1, 2000
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria
Patients must have:
- Absence of HIV-1 infection as documented by any licensed ELISA test kit within 14 days prior to study entry.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
- Any medical condition that, in the opinion of the investigator, would interfere with the patient's ability to participate in this protocol.
Patients with the following prior conditions and symptoms are excluded:
- History of chronic illness such as hypertension, coronary artery disease, arthritis, diabetes, or any chronic gastrointestinal conditions that might interfere with drug absorption.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | San Francisco Gen Hosp | San Francisco | California | United States | 941102859 |
2 | Univ of California/ San Francisco / Dept of Medicine | San Francisco | California | United States | 94110 |
3 | Stanford Univ Med Ctr | Stanford | California | United States | 943055107 |
4 | Johns Hopkins Hosp | Baltimore | Maryland | United States | 21287 |
Sponsors and Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
- Study Chair: Blaschke T,
- Study Chair: Flexner C,
- Study Chair: Sheiner L,
Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00000898
Other Study ID Numbers:
- ACTG 378
- 11339
First Posted:
Aug 31, 2001
Last Update Posted:
Oct 29, 2021
Last Verified:
Oct 1, 2021
Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID)
Additional relevant MeSH terms: